Physician profile
Boshen Liu
NPI 1588168611
$5,904.12
in general payments reported to CMS, 2019-2025
11 companies · $2,387 in 2025
The $2,387 reported for 2025 was more than what a typical Orthopaedic Surgery provider received nationally (typical 2025 total: $569).
Payments by year
General payments by program year, as reported to CMS.
General payments by year: 2019: $313 · 2021: $200 · 2022: $685 · 2023: $859 · 2024: $1,460 · 2025: $2,387.
What the payments were for
Nature of payment as categorized by the reporting companies: meals, consulting, travel, and so on.
Food and Beverage: $3,557 · Travel and Lodging: $1,149.
View as a table
| Payment type | Amount (2023-2025) |
|---|---|
| Food and Beverage | $3,556.94 |
| Travel and Lodging | $1,148.87 |
Payment-type detail covers 2023-2025; earlier years are included in totals but not broken out here.
Who reported paying
General payments only, as reported to CMS. Product names cover 2023-2025.
| Company | General payments | Years | Top products |
|---|---|---|---|
| Stryker Corporation | $2,958.67 | 2021-2025 | Pangea, T2 Alpha, Variax |
| Mf Med | $828.26 | 2024-2025 | |
| Arthrex, INC. | $596.45 | 2025 | |
| Smith+Nephew, INC. | $376.59 | 2023-2024 | Evos, Maverick, Trigen Intertan |
| Depuy Synthes Sales INC. | $319.25 | 2023-2024 | Na, Va-Lcp, Matrixmandible |
| Medical Device Business Services, INC. | $313.13 | 2019 | |
| Globus Medical, INC. | $174.93 | 2023 | Tibial Nail |
| Aroa Biosurgery Incorporated | $154.60 | 2025 | |
| Nevro Corp. | $126.32 | 2024 | Senza |
| Orthofix Medical, INC. | $39.91 | 2025 | Physio-Stim |
| Solventum Corporation | $16.01 | 2024 | V.A.C. Veraflo, Activ.A.C., V.A.C.Ulta |
Drugs and devices associated with these payments
CMS records which products a payment was associated with, not how the money was allocated. Association is not allocation: one payment can be associated with several products, and a product listing does not mean the payment was made because of that product. Product detail covers 2023-2025.
If you want to bring it up
Most clinicians are glad to talk about this. A respectful way in:
- "I saw Boshen Liu listed in the CMS Open Payments database. Can you tell me about your work with those companies?"
- "Is there a generic or alternative to this medication, and would it work as well for me?"
- "What made you choose this particular treatment for my situation?"
These are normal questions. A good clinician will welcome them.
Share this page
Keep an eye on this page
Get an email when the next June refresh changes this page. No account needed.
Source: CMS Open Payments, program years 2019-2025, as reported to CMS by drug and device makers (published June 30, 2026). Drug and device detail covers 2023-2025.